GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Izotropic IZO.CN · CAD

N/A · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.13

+8.70%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Izotropic

Its shares trade on Canadian Securities Exchange under the ticker IZO.CN. It has been listed since 31 May 2018.

Izotropic Corp. engages in the commercialization of proprietary diagnostic products for breast cancer. The company is headquartered in Surrey, British Columbia. The company went IPO on 2018-05-31. The firm is commercializing IzoView, a computed tomography (CT) imaging system, which produces images of anatomy for non-invasive tissue characterization with the first application in breast imaging. The firm has not generated any revenue.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
31 May 2018
Website
izocorp.com ↗

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Proprietary diagnostic products for breast cancer commercialization in CA
  • IzoView CT imaging system for non-invasive tissue characterization
  • First application in breast imaging with CT technology

Weaknesses

  • No revenue generation since inception
  • Headquarters in Surrey, British Columbia, CA
  • IPO listing date 31 May 2018

Opportunities

  • Commercialization of IzoView in breast imaging segment
  • Expansion into other medical imaging applications
  • Growing demand for non-invasive diagnostic technologies

Threats

  • No revenue generation affecting market position
  • Competition from established medical imaging firms
  • Regulatory challenges in healthcare sector

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.